Sponsored by
Tumor Treating Fields demonstrated good tolerability across >25,000 users, and the safety profile was consistent across subgroups (age, sex, and diagnosis). The most common treatment-related adverse events were skin reactions (43%), electric sensation (tingling; 14%) and heat sensation (warmth; 12%). Most treatment-related adverse events were manageable localized, non-serious skin events.